141
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress

, , , &
Pages 433-439 | Received 24 May 2015, Accepted 30 Jun 2015, Published online: 31 Jul 2015

References

  • Candel I, Aznar E, Mondragón L, et al. (2012). Amidase-responsive controlled release of antitumoral drug into intracellular media using gluconamide-capped mesoporous silica nanoparticles. Nanoscale 4:7237–45
  • De Jong WH, Borm PJ. (2008). Drug delivery and nanoparticles: applications and hazards. Int J Nanomed 3:133–49
  • Giri S, Trewyn BG, Stellmaker MP, Lin VS. (2005). Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angew Chem Int Ed Engl 44:5038–44
  • Hanafi-Bojd MY, Jaafari MR, Ramezanian N, et al. (2015). Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells. Eur J Pharm Biopharm 89:248–58
  • Hsiao JK, Tsai CP, Chung TH, et al. (2008). Mesoporous silica nanoparticles as a delivery system of gadolinium for effective human stem cell tracking. Small 4:1445–52
  • Huang X, Teng X, Chen D, et al. (2010). The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials 31:438–48
  • Kresge C, Leonowicz M, Roth W, et al. (1992). Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 359:710–12
  • Lu J, Liong M, Zink JI, Tamanoi F. (2007). Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 3:1341–6
  • Mahmoudi A, Kazemi Oskuee R, Ramezani M, Malaekeh-Nikoue B. (2014). Preparation and in vitro transfection efficiency evaluation of modified cationic liposome–polyethyleneimine-plasmid nanocomplexes as a novel gene carrier. Curr Drug Deliv 11:636–42
  • Maynard AD, Warheit DB, Philbert MA. (2011). The new toxicology of sophisticated materials: nanotoxicology and beyond. Toxicol Sci 120:S109–29
  • Mehri S, Abnous K, Mousavi SH, et al. (2012). Neuroprotective effect of crocin on acrylamide-induced cytotoxicity in PC12 cells. Cell Mol Neurobiol 32:227–35
  • Meng H, Liong M, Xia T, et al. (2010). Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and p-glycoprotein siRNA to overcome drug resistance in a cancer cell line. ACS Nano 4:4539–50
  • Radu DR, Lai CY, Jeftinija K, et al. (2004). A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. J Am Chem Soc 126:13216–17
  • Razavi-Azarkhiavi K, Behravan J, Mosaffa F, et al. (2013). Protective effects of aqueous and ethanol extracts of rosemary on H2O2-induced oxidative DNA damage in human lymphocytes by comet assay. J Complement Integr Med 11:27–33
  • Rezaee R, Behravan E, Behravan J, et al. (2013). Antigenotoxic activities of the natural dietary coumarins umbelliferone, herniarin and 7-isopentenyloxy coumarin on human lymphocytes exposed to oxidative stress. Drug Chem Toxicol 37:144–8
  • Rezaee R, Jamialahmadi K, Zanjani BR, et al. (2014). Crocin effects on human myeloma cells regarding intracellular redox state, DNA fragmentation, and apoptosis or necrosis profile. Jundishapur J Nat Pharm Prod 9:e20131
  • Rosenholm JM, Sahlgren C, Lindén M. (2010). Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles – opportunities & challenges. Nanoscale 2:1870–83
  • Sadeghnia HR, Hassani FV, Sadeghian H, et al. (2013). Evaluation of in vitro toxicity of peptide (N-acetyl-Leu-Gly-Leu-COOH)-substituted-β-cyclodextrin derivative, a novel drug carrier, in PC-12 cells. DARU J Pharm Sci 21:75
  • Singh NP, McCoy MT, Tice RR, Schneider EL. (1988). A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184–91
  • Slowing II, Trewyn BG, Giri S, Lin VY. (2007). Mesoporous silica nanoparticles for drug delivery and biosensing applications. Adv Funct Mater 17:1225–36
  • Slowing II, Vivero-Escoto JL, Wu C-W, Lin VS-Y. (2008). Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 60:1278–88
  • Tao Z, Morrow MP, Asefa T, et al. (2008). Mesoporous silica nanoparticles inhibit cellular respiration. Nano Lett 8:1517–26
  • Tao Z, Toms BB, Goodisman J, Asefa T. (2009). Mesoporosity and functional group dependent endocytosis and cytotoxicity of silica nanomaterials. Chem Res Toxicol 22:1869–80
  • Thassu D, Pathak Y, Deleers M. (2007). Nanoparticulate drug-delivery systems: an overview. In Thassu D, Deelers M, Pathak Y, eds. Nanoparticulate drug delivery systems. London: Informa Healthcare, 1–31
  • Torney F, Trewyn BG, Lin VS, Wang K. (2007). Mesoporous silica nanoparticles deliver DNA and chemicals into plants. Nat Nanotechnol 2:295–300
  • Trewyn BG, Nieweg JA, Zhao Y, Lin VSY. (2008). Biocompatible mesoporous silica nanoparticles with different morphologies for animal cell membrane penetration. Chem Eng J 137:23–9
  • Uchiyama M, Mihara M. (1978). Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86:271–8
  • Vallet-Regí M, Balas F, Arcos D. (2007). Mesoporous materials for drug delivery. Angew Chem Int Ed Engl 46:7548–58
  • Yu T, Greish K, McGill LD, et al. (2012). Influence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: their vasculature effect and tolerance threshold. ACS Nano 6:2289–301
  • Zarei H, Rezaee R, Behravan E, et al. (2013). Diversin, from Ferula diversivittata protects human lymphocytes against oxidative stress induced by H2O2. Nat Prod Res 27:1016–19

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.